US 10925961
Vaccines with CD40 ligand as an adjuvant
granted A61KA61K2039/53A61K2039/55516
Quick answer
US patent 10925961 (Vaccines with CD40 ligand as an adjuvant) held by Inovio Pharmaceuticals, Inc. expires Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K2039/53, A61K2039/55516, A61K2039/585, A61K39/0011